Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Protein engineering produces ’molecular switch’

28.03.2003


In this Johns Hopkins engineering lab, Gurkan Guntas and Marc Ostermeier used a technique called domain insertion to join two proteins and create a molecular ’switch.’
Photo by Will Kirk


Technique could lead to new drug delivery systems, biological warfare sensors

Using a lab technique called domain insertion, Johns Hopkins researchers have joined two proteins in a way that creates a molecular “switch.” The result, the researchers say, is a microscopic protein partnership in which one member controls the activity of the other. Similarly coupled proteins may someday be used to produce specialized molecules that deliver lethal drugs only to cancerous cells. They also might be used to set off a warning signal when biological warfare agents are present.

The technique used to produce this molecular switch was reported March 27 in New Orleans at the 225th national meeting of the American Chemical Society,



“We’ve taken two proteins that normally have nothing to do with one another, spliced them together genetically and created a fusion protein in which the two components now ‘talk’ to one another,” said Marc Ostermeier, assistant professor in the Department of Chemical and Biomolecular Engineering at Johns Hopkins. “More important, we’ve shown that one of these partners is able to modulate or control the activity of the other. This could lead to very exciting practical applications in medical treatment and bio-sensing.”

To prove the production of a molecular switch is possible, Ostermeier, assisted by doctoral student Gurkan Guntas, started with two proteins that typically do not interact: beta-lactamase and the maltose binding protein found in a harmless form of E. coli bacteria. Each protein has a distinct activity that makes it easy to monitor. Beta-lactamase is an enzyme that can disable and degrade penicillin-like antibiotics. Maltose binding protein binds to a type of sugar called maltose that the E. coli cells can use as food.

Using a technique called domain insertion, the Johns Hopkins researchers placed beta-lactamase genes inside genes for maltose binding protein. To do this, they snipped the maltose binding genes, using enzymes that act like molecular scissors to cut the genes as though they were tiny strips of paper. A second enzyme was used to re-attach these severed strips to each side of a beta-lactamase gene, producing a single gene strip measuring approximately the combined length of the original pieces. This random cut-and-paste process took place within a test tube and created hundreds of thousands of combined genes. Because the pieces were cut and reassembled at different locations along the maltose binding gene, the combined genes produced new proteins with different characteristics.

Ostermeier believed a very small number of these new fusion proteins might possess the molecular switch behavior he was looking for. To find them, he and Guntas took a cue from the process of evolution, or “survival of the fittest.” By looking for the E. coli that thrived in maltose, they could isolate only the ones in which the maltose binding partner was still active (in other words, it still bound itself to maltose). By then mixing them with an antibiotic, the researchers could find the ones in which the beta-lactamase remained active and capable of reacting against the antibiotic. Through such survival tests, the researchers ultimately were able to find two fusion proteins in which not only were both proteins still active, but in which the presence of maltose actually caused the beta-lactamase partner to step up its attack on an antibiotic.

“In other words,” Ostermeier said, “one part of this coupled protein sent a signal, telling the other part to change its behavior. This is the first clear demonstration that you can apply the domain insertion technique to control the activity of an enzyme. If we can replicate this with other proteins, we can create biological agents that don’t exist in nature but can be very useful in important applications.”

For example, Ostermeier said, one part of a fusion protein might react only to cancer cells, signaling its partner to release a toxin to kill the diseased tissue. Healthy cells, however, would not set off the switch and would thus be left unharmed. Ostermeier also suggested that one part of a fusion protein might react to the presence of a biological warfare agent, signaling its partner to set off a bright green flourescent glow that could alert soldiers and others to the danger.

The Johns Hopkins University has applied for U.S. and international patents related to Ostermeier’s molecular switch technology and the techniques used to produce them. Ostermeier’s research has been funded by grants from the American Cancer Society and the Maryland Cigarette Restitution Fund.

Phil Sneiderman | EurekAlert!
Further information:
http://www.jhu.edu/
http://www.jhu.edu/news_info/news/home03/mar03/molecule.html
http://www.jhu.edu/chbe/index.asp

More articles from Life Sciences:

nachricht Scientists spin artificial silk from whey protein
24.01.2017 | Deutsches Elektronen-Synchrotron DESY

nachricht Choreographing the microRNA-target dance
24.01.2017 | UT Southwestern Medical Center

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Scientists spin artificial silk from whey protein

X-ray study throws light on key process for production

A Swedish-German team of researchers has cleared up a key process for the artificial production of silk. With the help of the intense X-rays from DESY's...

Im Focus: Quantum optical sensor for the first time tested in space – with a laser system from Berlin

For the first time ever, a cloud of ultra-cold atoms has been successfully created in space on board of a sounding rocket. The MAIUS mission demonstrates that quantum optical sensors can be operated even in harsh environments like space – a prerequi-site for finding answers to the most challenging questions of fundamental physics and an important innovation driver for everyday applications.

According to Albert Einstein's Equivalence Principle, all bodies are accelerated at the same rate by the Earth's gravity, regardless of their properties. This...

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Breaking the optical bandwidth record of stable pulsed lasers

24.01.2017 | Physics and Astronomy

Choreographing the microRNA-target dance

24.01.2017 | Life Sciences

Spanish scientists create a 3-D bioprinter to print human skin

24.01.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>